Financial results - VITAEPHARM SRL

Financial Summary - Vitaepharm Srl
Unique identification code: 4594267
Registration number: J1993001414107
Nace: 4773
Sales - Ron
1.826.893
Net Profit - Ron
175.228
Employees
18
Open Account
Company Vitaepharm Srl with Fiscal Code 4594267 recorded a turnover of 2024 of 1.826.893, with a net profit of 175.228 and having an average number of employees of 18. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Vitaepharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 315.597 346.294 466.016 560.151 631.293 799.644 901.710 1.117.960 1.377.882 1.826.893
Total Income - EUR 315.695 347.223 467.028 560.630 631.764 799.645 901.715 1.117.970 1.379.746 1.829.714
Total Expenses - EUR 355.146 351.789 447.433 544.053 586.865 753.465 871.329 1.027.904 1.212.920 1.621.972
Gross Profit/Loss - EUR -39.452 -4.566 19.595 16.577 44.899 46.181 30.386 90.065 166.826 207.742
Net Profit/Loss - EUR -39.452 -4.566 15.029 10.971 38.582 38.184 22.436 81.424 139.759 175.228
Employees 6 7 8 0 9 10 12 13 14 18
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 33.3%, from 1.377.882 euro in the year 2023, to 1.826.893 euro in 2024. The Net Profit increased by 36.251 euro, from 139.759 euro in 2023, to 175.228 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Vitaepharm Srl

Rating financiar

Financial Rating -
VITAEPHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Vitaepharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Vitaepharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Vitaepharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Vitaepharm Srl - CUI 4594267

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 6.149 5.922 5.645 19.371 20.568 16.716 19.002 14.298 48.585 102.462
Current Assets 110.449 99.308 184.886 250.347 243.757 322.933 403.805 475.768 569.951 749.673
Inventories 75.224 80.929 102.346 128.873 161.624 194.759 193.128 242.067 297.948 442.670
Receivables 32.946 16.524 68.165 99.975 71.577 114.072 134.897 191.968 223.373 183.466
Cash 2.279 1.856 14.375 21.499 10.556 14.103 75.780 41.734 48.630 123.536
Shareholders Funds 15.602 10.877 25.722 21.489 38.653 38.254 54.262 123.445 153.904 175.297
Social Capital 45 45 44 64 63 62 61 61 61 60
Debts 100.996 94.353 164.809 248.229 225.671 301.394 368.544 366.622 464.632 676.838
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 749.673 euro in 2024 which includes Inventories of 442.670 euro, Receivables of 183.466 euro and cash availability of 123.536 euro.
The company's Equity was valued at 175.297 euro, while total Liabilities amounted to 676.838 euro. Equity increased by 22.252 euro, from 153.904 euro in 2023, to 175.297 in 2024.

Risk Reports Prices

Reviews - Vitaepharm Srl

Comments - Vitaepharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.